摘要

We developed a fully recombinant anti-CD20 protein derived from cDNA encoding one Fab domain, two IgG1 Fc regions, the IgG2 hinge, and an isoleucine zipper. This protein, called GB4542, contained both the homodimer and higher-order multimers. Binding studies revealed that GB4542 preferentially bound CD20(+) cells yet also recognized CD20(-) Fc gamma R+ PBMC. In contrast, a control mAb containing the identical Fab region, GB4500, failed to bind CD20(-) Fc gamma R+ PBMC. Consistent with these findings, interactions between GB4542 and the canonical Fc gamma Rs had substantially lower K-D values than correlate interfaces between GB4500 and these receptors. At low concentrations, GB4542 showed enhanced Ab-dependent cellular cytotoxicity, Ab-dependent cellular phagocytosis, and complement-dependent cytotoxicity compared with GB4500. However, at higher concentrations, an Fc analog of GB4542 inhibited anti-CD20 mAb mediated B cell clearance through direct blocking of both Fc-Fc gamma R interactions and C1q deposition on target cells. Furthermore, the higher-order multimer fraction of GB4542 demonstrated greater binding avidity with the canonical FcyRs and was associated with inhibitory effects observed in Ab-dependent cellular phagocytosis and complement dependent cytotoxicity assays. These data suggest that GB4542 might have utility in the treatment of autoimmune diseases by combining both mAb-mediated B cell depletion and multimerized Fc-mediated tolerogenic effects.